{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:43:35Z","timestamp":1773290615717,"version":"3.50.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,5,22]],"date-time":"2013-05-22T00:00:00Z","timestamp":1369180800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1476-511x-12-74","type":"journal-article","created":{"date-parts":[[2013,5,22]],"date-time":"2013-05-22T08:14:48Z","timestamp":1369210488000},"source":"Crossref","is-referenced-by-count":10,"title":["Plasma folate, but not homocysteine, is associated with Apolipoprotein A1 levels in a non-fortified population"],"prefix":"10.1186","volume":"12","author":[{"given":"Elisabet","family":"S\u00f6derstr\u00f6m","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Eliasson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owe","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6ran","family":"Hallmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Weinehall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-H\u00e5kan","family":"Jansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Hultdin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,22]]},"reference":[{"key":"889_CR1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1365-2796.2009.02077.x","volume":"266","author":"B Van Guelpen","year":"2009","unstructured":"Van Guelpen B, Hultdin J, Johansson I, Witth\u00f6ft C, Weinehall L, Eliasson M, Hallmans G, Palmqvist R, Jansson JH, Winkvist A: Plasma folate and total homocysteine levels are associated with the risk of myocardial infarction, independently of each other and of renal function. J Intern Med. 2009, 266: 182-195. 10.1111\/j.1365-2796.2009.02077.x","journal-title":"J Intern Med"},{"key":"889_CR2","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","volume":"325","author":"DS Wald","year":"2002","unstructured":"Wald DS, Law M, Morris JK: Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ. 2002, 325: 1202- 10.1136\/bmj.325.7374.1202","journal-title":"BMJ"},{"key":"889_CR3","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1001\/jama.288.16.2015","volume":"288","author":"The Homocysteine Studies Collaboration","year":"2002","unstructured":", : Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002, 288: 2015-2022. 10.1001\/jama.288.16.2015","journal-title":"JAMA"},{"key":"889_CR4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/ije\/31.1.59","volume":"31","author":"ES Ford","year":"2002","unstructured":"Ford ES, Smith SJ, Stroup DF, Steinberg KK, Mueller PW, Thacker SB: Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case\u2013control studies and nested case\u2013control studies. Int J Epidemiol. 2002, 31: 59-70. 10.1093\/ije\/31.1.59","journal-title":"Int J Epidemiol"},{"key":"889_CR5","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/S0895-4356(02)00434-1","volume":"55","author":"LE Bautista","year":"2002","unstructured":"Bautista LE, Arenas IA, Penuela A, Martinez LX: Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies. J Clin Epidemiol. 2002, 55: 882-887. 10.1016\/S0895-4356(02)00434-1","journal-title":"J Clin Epidemiol"},{"key":"889_CR6","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1161\/01.CIR.0000112581.96154.EA","volume":"109","author":"DE Zylberstein","year":"2004","unstructured":"Zylberstein DE, Bengtsson C, Bj\u00f6rkelund C, Landaas S, Sundh V, Thelle D, Lissner L: Serum homocysteine in relation to mortality and morbidity from coronary heart disease: a 24-year follow-up of the population study of women in Gothenburg. Circulation. 2004, 109: 601-606. 10.1161\/01.CIR.0000112581.96154.EA","journal-title":"Circulation"},{"key":"889_CR7","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.atherosclerosis.2007.09.029","volume":"198","author":"R Cui","year":"2008","unstructured":"Cui R, Moriyama Y, Koike KA, Date C, Kikuchi S, Tamakoshi A, Iso H: Serum total homocysteine concentrations and risk of mortality from stroke and coronary heart disease in Japanese: The JACC study. Atherosclerosis. 2008, 198: 412-418. 10.1016\/j.atherosclerosis.2007.09.029","journal-title":"Atherosclerosis"},{"key":"889_CR8","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s10545-010-9235-y","volume":"34","author":"R Clarke","year":"2011","unstructured":"Clarke R, Halsey J, Bennett D, Lewington S: Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials. J Inherit Metab Dis. 2011, 34: 83-91. 10.1007\/s10545-010-9235-y","journal-title":"J Inherit Metab Dis"},{"key":"889_CR9","doi-asserted-by":"publisher","first-page":"e25142","DOI":"10.1371\/journal.pone.0025142","volume":"6","author":"YH Zhou","year":"2011","unstructured":"Zhou YH, Tang JY, Wu MJ, Lu J, Wei X, Qin YY, Wang C, Xu JF, He J: Effect of folic acid supplementation on cardiovascular outcomes: a systematic review and meta-analysis. PLoS One. 2011, 6: e25142- 10.1371\/journal.pone.0025142","journal-title":"PLoS One"},{"key":"889_CR10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/j.1755-5922.2011.00266.x","volume":"30","author":"B Debreceni","year":"2012","unstructured":"Debreceni B, Debreceni L: Why do homocysteine-lowering B vitamin and antioxidant E vitamin supplementations appear to be ineffective in the prevention of cardiovascular diseases?. Cardiovasc Ther. 2012, 30: 227-233. 10.1111\/j.1755-5922.2011.00266.x","journal-title":"Cardiovasc Ther"},{"key":"889_CR11","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1172\/JCI10588","volume":"107","author":"MA Hofmann","year":"2001","unstructured":"Hofmann MA, Lalla E, Lu Y, Gleason MR, Wolf BM, Tanji N, Ferran LJ, Kohl B, Rao V, Kisiel W: Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest. 2001, 107: 675-683. 10.1172\/JCI10588","journal-title":"J Clin Invest"},{"key":"889_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-511X-5-1","volume":"5","author":"P Sharma","year":"2006","unstructured":"Sharma P, Senthilkumar RD, Brahmachari V, Sundaramoorthy E, Mahajan A, Sharma A, Sengupta S: Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies. Lipids Health Dis. 2006, 5: 1- 10.1186\/1476-511X-5-1","journal-title":"Lipids Health Dis"},{"key":"889_CR13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-2275(20)43114-1","volume":"9","author":"JA Glomset","year":"1968","unstructured":"Glomset JA: The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res. 1968, 9: 155-167.","journal-title":"J Lipid Res"},{"key":"889_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.pharmthera.2010.12.003","volume":"130","author":"DO Osei-Hwedieh","year":"2011","unstructured":"Osei-Hwedieh DO, Amar M, Sviridov D, Remaley AT: Apolipoprotein mimetic peptides: Mechanisms of action as anti-atherogenic agents. Pharmacol Ther. 2011, 130: 83-91. 10.1016\/j.pharmthera.2010.12.003","journal-title":"Pharmacol Ther"},{"key":"889_CR15","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","volume":"8","author":"M Navab","year":"2011","unstructured":"Navab M, Reddy ST, Van Lenten BJ, Fogelman AM: HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat Rev Cardiol. 2011, 8: 222-232. 10.1038\/nrcardio.2010.222","journal-title":"Nat Rev Cardiol"},{"key":"889_CR16","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1161\/01.RES.0000214406.87060.e0","volume":"98","author":"AM Devlin","year":"2006","unstructured":"Devlin AM, Lentz SR: ApoA-I: a missing link between homocysteine and lipid metabolism?. Circ Res. 2006, 98: 431-433. 10.1161\/01.RES.0000214406.87060.e0","journal-title":"Circ Res"},{"key":"889_CR17","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1001\/jama.1992.03490070059042","volume":"268","author":"MJ Stampfer","year":"1992","unstructured":"Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Hennekens CH: A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA. 1992, 268: 877-881. 10.1001\/jama.1992.03490070059042","journal-title":"JAMA"},{"key":"889_CR18","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1161\/01.CIR.102.11.1227","volume":"102","author":"JL Anderson","year":"2000","unstructured":"Anderson JL, Muhlestein JB, Horne BD, Carlquist JF, Bair TL, Madsen TE, Pearson RR: Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease. Circulation. 2000, 102: 1227-1232. 10.1161\/01.CIR.102.11.1227","journal-title":"Circulation"},{"key":"889_CR19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0009-9120(01)00187-4","volume":"34","author":"D Qujeq","year":"2001","unstructured":"Qujeq D, Omran TS, Hosini L: Correlation between total homocysteine, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol in the serum of patients with myocardial infarction. Clin Biochem. 2001, 34: 97-101. 10.1016\/S0009-9120(01)00187-4","journal-title":"Clin Biochem"},{"key":"889_CR20","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.atherosclerosis.2010.11.031","volume":"214","author":"RM Gueant-Rodriguez","year":"2011","unstructured":"Gueant-Rodriguez RM, Spada R, Moreno-Garcia M, Anello G, Bosco P, Lagrost L, Romano A, Elia M, Gueant JL: Homocysteine is a determinant of ApoA-I and both are associated with ankle brachial index, in an ambulatory elderly population. Atherosclerosis. 2011, 214: 480-485. 10.1016\/j.atherosclerosis.2010.11.031","journal-title":"Atherosclerosis"},{"key":"889_CR21","doi-asserted-by":"publisher","first-page":"815","DOI":"10.5551\/jat.2196","volume":"16","author":"JT Real","year":"2009","unstructured":"Real JT, Martinez-Hervas S, Garcia-Garcia AB, Chaves FJ, Civera M, Ascaso JF, Carmena R: Association of C677T polymorphism in MTHFR gene, high homocysteine and low HDL cholesterol plasma values in heterozygous familial hypercholesterolemia. J Atheroscler Thromb. 2009, 16: 815-820.","journal-title":"J Atheroscler Thromb"},{"key":"889_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/00365510701487735","volume":"68","author":"A Collings","year":"2008","unstructured":"Collings A, Raitakari OT, Juonala M, Rontu R, Kahonen M, Hutri-Kahonen N, Ronnemaa T, Marniemi J, Viikari JS, Lehtimaki T: Associations of methylenetetrahydrofolate reductase C677T polymorphism with markers of subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study. Scand J Clin Lab Invest. 2008, 68: 22-30. 10.1080\/00365510701487735","journal-title":"Scand J Clin Lab Invest"},{"key":"889_CR23","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1161\/01.RES.0000242559.42077.22","volume":"99","author":"D Liao","year":"2006","unstructured":"Liao D, Tan H, Hui R, Li Z, Jiang X, Gaubatz J, Yang F, Durante W, Chan L, Schafer AI: Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I Protein synthesis and enhancing HDL cholesterol clearance. Circ Res. 2006, 99: 598-606. 10.1161\/01.RES.0000242559.42077.22","journal-title":"Circ Res"},{"key":"889_CR24","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1515\/CCLM.2007.358","volume":"45","author":"D Liao","year":"2007","unstructured":"Liao D, Yang X, Wang H: Hyperhomocysteinemia and high-density lipoprotein metabolism in cardiovascular disease. Clin Chem Lab Med. 2007, 45: 1652-1659.","journal-title":"Clin Chem Lab Med"},{"key":"889_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/1476-511X-10-137","volume":"10","author":"Y Xiao","year":"2011","unstructured":"Xiao Y, Zhang Y, Lv X, Su D, Li D, Xia M, Qiu J, Ling W, Ma J: Relationship between lipid profiles and plasma total homocysteine, cysteine and the risk of coronary artery disease in coronary angiographic subjects. Lipids Health Dis. 2011, 10: 137- 10.1186\/1476-511X-10-137","journal-title":"Lipids Health Dis"},{"key":"889_CR26","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1161\/01.CIR.98.23.2520","volume":"98","author":"L Brattstr\u00f6m","year":"1998","unstructured":"Brattstr\u00f6m L, Wilcken DE, Ohrvik J, Brudin L: Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation. 1998, 98: 2520-2526. 10.1161\/01.CIR.98.23.2520","journal-title":"Circulation"},{"key":"889_CR27","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1161\/01.RES.0000204825.66410.0b","volume":"98","author":"LG Mikael","year":"2006","unstructured":"Mikael LG, Genest J, Rozen R: Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease. Circ Res. 2006, 98: 564-571. 10.1161\/01.RES.0000204825.66410.0b","journal-title":"Circ Res"},{"key":"889_CR28","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1016\/j.atherosclerosis.2007.06.030","volume":"195","author":"BC Schwahn","year":"2007","unstructured":"Schwahn BC, Wang XL, Mikael LG, Wu Q, Cohn J, Jiang H, Maclean KN, Rozen R: Betaine supplementation improves the atherogenic risk factor profile in a transgenic mouse model of hyperhomocysteinemia. Atherosclerosis. 2007, 195: e100-107. 10.1016\/j.atherosclerosis.2007.06.030","journal-title":"Atherosclerosis"},{"key":"889_CR29","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1161\/01.RES.0000243583.39694.1f","volume":"99","author":"PJ Barter","year":"2006","unstructured":"Barter PJ, Rye KA: Homocysteine and cardiovascular disease: is HDL the link?. Circ Res. 2006, 99: 565-566. 10.1161\/01.RES.0000243583.39694.1f","journal-title":"Circ Res"},{"key":"889_CR30","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.numecd.2011.01.008","volume":"22","author":"AK Elshorbagy","year":"2012","unstructured":"Elshorbagy AK, Valdivia-Garcia M, Graham IM, Palma Reis R, Sales Luis A, Smith AD, Refsum H: The association of fasting plasma sulfur-containing compounds with BMI, serum lipids and apolipoproteins. Nutr Metab Cardiovasc Dis. 2012, 22: 1031-1038. 10.1016\/j.numecd.2011.01.008","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"889_CR31","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1093\/hmg\/ddp159","volume":"18","author":"F Drenos","year":"2009","unstructured":"Drenos F, Talmud PJ, Casas JP, Smeeth L, Palmen J, Humphries SE, Hingorani AD: Integrated associations of genotypes with multiple blood biomarkers linked to coronary heart disease risk. Hum Mol Genet. 2009, 18: 2305-2316. 10.1093\/hmg\/ddp159","journal-title":"Hum Mol Genet"},{"key":"889_CR32","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1258\/acb.2010.010035","volume":"47","author":"N Ishimine","year":"2010","unstructured":"Ishimine N, Usami Y, Nogi S, Sumida T, Kurihara Y, Matsuda K, Nakamura K, Yamauchi K, Okumura N, Tozuka M: Identification of N-homocysteinylated apolipoprotein AI in normal human serum. Ann Clin Biochem. 2010, 47: 453-459. 10.1258\/acb.2010.010035","journal-title":"Ann Clin Biochem"},{"key":"889_CR33","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.atherosclerosis.2004.07.020","volume":"177","author":"I Shai","year":"2004","unstructured":"Shai I, Stampfer MJ, Ma J, Manson JE, Hankinson SE, Cannuscio C, Selhub J, Curhan G, Rimm EB: Homocysteine as a risk factor for coronary heart diseases and its association with inflammatory biomarkers, lipids and dietary factors. Atherosclerosis. 2004, 177: 375-381. 10.1016\/j.atherosclerosis.2004.07.020","journal-title":"Atherosclerosis"},{"key":"889_CR34","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0021-9150(99)00202-6","volume":"147","author":"B Christensen","year":"1999","unstructured":"Christensen B, Landaas S, Stensvold I, Djurovic S, Retterstol L, Ringstad J, Berg K, Thelle DS: Whole blood folate, homocysteine in serum, and risk of first acute myocardial infarction. Atherosclerosis. 1999, 147: 317-326. 10.1016\/S0021-9150(99)00202-6","journal-title":"Atherosclerosis"},{"key":"889_CR35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3109\/09637486.2010.529072","volume":"62","author":"F Shidfar","year":"2011","unstructured":"Shidfar F, Froghifar N, Vafa M, Rajab A, Hosseini S, Shidfar S, Gohari M: The effects of tomato consumption on serum glucose, apolipoprotein B, apolipoprotein A-I, homocysteine and blood pressure in type 2 diabetic patients. Int J Food Sci Nutr. 2011, 62: 289-294. 10.3109\/09637486.2010.529072","journal-title":"Int J Food Sci Nutr"},{"key":"889_CR36","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1161\/ATVBAHA.108.178228","volume":"29","author":"MR Taskinen","year":"2009","unstructured":"Taskinen MR, Sullivan DR, Ehnholm C, Whiting M, Zannino D, Simes RJ, Keech AC, Barter PJ: Relationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with type 2 diabetes treated with fenofibrate. Arterioscler Thromb Vasc Biol. 2009, 29: 950-955. 10.1161\/ATVBAHA.108.178228","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"889_CR37","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.atherosclerosis.2010.04.028","volume":"212","author":"M Nuno-Ayala","year":"2010","unstructured":"Nuno-Ayala M, Guillen N, Navarro MA, Lou-Bonafonte JM, Arnal C, Gascon S, Barranquero C, Godino J, Royo-Canas M, Sarria AJ: Cysteinemia, rather than homocysteinemia, is associated with plasma apolipoprotein A-I levels in hyperhomocysteinemia: lipid metabolism in cystathionine beta-synthase deficiency. Atherosclerosis. 2010, 212: 268-273. 10.1016\/j.atherosclerosis.2010.04.028","journal-title":"Atherosclerosis"},{"key":"889_CR38","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10552-009-9484-y","volume":"21","author":"B Van Guelpen","year":"2010","unstructured":"Van Guelpen B, Dahlin AM, Hultdin J, Eklof V, Johansson I, Henriksson ML, Cullman I, Hallmans G, Palmqvist R: One-carbon metabolism and CpG island methylator phenotype status in incident colorectal cancer: a nested case-referent study. Cancer Causes Control. 2010, 21: 557-566. 10.1007\/s10552-009-9484-y","journal-title":"Cancer Causes Control"},{"key":"889_CR39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jn\/135.1.5","volume":"135","author":"S Zaina","year":"2005","unstructured":"Zaina S, Lindholm MW, Lund G: Nutrition and aberrant DNA methylation patterns in atherosclerosis: more than just hyperhomocysteinemia?. J Nutr. 2005, 135: 5-8.","journal-title":"J Nutr"},{"key":"889_CR40","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/jn\/135.6.1382","volume":"135","author":"KA Lillycrop","year":"2005","unstructured":"Lillycrop KA, Phillips ES, Jackson AA, Hanson MA, Burdge GC: Dietary protein restriction of pregnant rats induces and folic acid supplementation prevents epigenetic modification of hepatic gene expression in the offspring. J Nutr. 2005, 135: 1382-1386.","journal-title":"J Nutr"},{"key":"889_CR41","doi-asserted-by":"crossref","unstructured":"Gueant JL, Namour F, Gueant-Rodriguez RM, Daval JL: Folate and fetal programming: a play in epigenomics. Trends Endocrinol Metab. in press","DOI":"10.1016\/j.tem.2013.01.010"},{"key":"889_CR42","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1172\/JCI30163","volume":"116","author":"DJ Rader","year":"2006","unstructured":"Rader DJ: Molecular regulation of HDL metabolism and function: implications for novel therapies. J Clin Invest. 2006, 116: 3090-3100. 10.1172\/JCI30163","journal-title":"J Clin Invest"},{"key":"889_CR43","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/00005344-200403000-00017","volume":"43","author":"G Luc","year":"2004","unstructured":"Luc G, Jacob N, Bouly M, Fruchart JC, Staels B, Giral P: Fenofibrate increases homocystinemia through a PPARalpha-mediated mechanism. J Cardiovasc Pharmacol. 2004, 43: 452-453. 10.1097\/00005344-200403000-00017","journal-title":"J Cardiovasc Pharmacol"},{"key":"889_CR44","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/cvr\/cvn157","volume":"80","author":"LG Mikael","year":"2008","unstructured":"Mikael LG, Rozen R: Homocysteine modulates the effect of simvastatin on expression of ApoA-I and NF-kappaB\/iNOS. Cardiovasc Res. 2008, 80: 151-158. 10.1093\/cvr\/cvn157","journal-title":"Cardiovasc Res"},{"key":"889_CR45","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s11883-012-0230-7","volume":"14","author":"EA Brinton","year":"2012","unstructured":"Brinton EA: Effects of ethanol intake on lipoproteins. Curr Atheroscler Rep. 2012, 14: 108-114. 10.1007\/s11883-012-0230-7","journal-title":"Curr Atheroscler Rep"},{"key":"889_CR46","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/14034950310001432","volume":"61","author":"G Hallmans","year":"2003","unstructured":"Hallmans G, \u00c5gren \u00c5, Johansson G, Johansson A, Stegmayr B, Jansson JH, Lindahl B, Rolandsson O, S\u00f6derberg S, Nilsson M: Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort - evaluation of risk factors and their interactions. Scand J Public Health Suppl. 2003, 61: 18-24.","journal-title":"Scand J Public Health Suppl"},{"key":"889_CR47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/14034950310001441","volume":"61","author":"B Stegmayr","year":"2003","unstructured":"Stegmayr B, Lundberg V, Asplund K: The events registration and survey procedures in the Northern Sweden MONICA Project. Scand J Public Health Suppl. 2003, 61: 9-17.","journal-title":"Scand J Public Health Suppl"},{"key":"889_CR48","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/028134398750003133","volume":"16","author":"L Weinehall","year":"1998","unstructured":"Weinehall L, Hallgren CG, Westman G, Janlert U, Wall S: Reduction of selection bias in primary prevention of cardiovascular disease through involvement of primary health care. Scand J Prim Health Care. 1998, 16: 171-176. 10.1080\/028134398750003133","journal-title":"Scand J Prim Health Care"},{"key":"889_CR49","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0378-5122(85)90016-7","volume":"7","author":"A Hagstad","year":"1985","unstructured":"Hagstad A, Johansson S, Wilhelmsson C, Janson PO: Gynaecology of middle-aged women\u2013menstrual and reproductive histories. Maturitas. 1985, 7: 99-113. 10.1016\/0378-5122(85)90016-7","journal-title":"Maturitas"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-511X-12-74.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1476-511X-12-74\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-511X-12-74.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,17]],"date-time":"2022-02-17T16:50:25Z","timestamp":1645116625000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/1476-511X-12-74"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,22]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["889"],"URL":"https:\/\/doi.org\/10.1186\/1476-511x-12-74","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,22]]},"article-number":"74"}}